Sage Therapeutic Stock Price on October 14, 2024
| SAGE Stock | USD 5.00 0.03 0.60% |
Below is the normalized historical share price chart for Sage Therapeutic extending back to July 18, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sage Therapeutic stands at 5.00, as last reported on the 20th of December, with the highest price reaching 5.16 and the lowest price hitting 4.96 during the day.
If you're considering investing in Sage Stock, it is important to understand the factors that can impact its price. Sage Therapeutic owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0988, which indicates the firm had a -0.0988% return per unit of risk over the last 3 months. Sage Therapeutic exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sage Therapeutic's Variance of 21.99, coefficient of variation of (912.07), and Risk Adjusted Performance of (0.08) to confirm the risk estimate we provide.
The current year's Total Stockholder Equity is expected to grow to about 802.6 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 45.7 M. . At present, Sage Therapeutic's Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 1.70, whereas Price Earnings Ratio is forecasted to decline to (2.51). Sage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of July 2014 | 200 Day MA 10.4804 | 50 Day MA 6.1656 | Beta 0.924 |
Sage |
Sharpe Ratio = -0.0988
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SAGE |
Estimated Market Risk
| 4.71 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.47 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sage Therapeutic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sage Therapeutic by adding Sage Therapeutic to a well-diversified portfolio.
Price Book 0.5576 | Enterprise Value Ebitda (0.33) | Price Sales 2.892 | Shares Float 48.5 M | Wall Street Target Price 9 |
Related Headline
Relay Therapeutics Headline on 14th of October 2024
Relay Therapeutics Receives Buy Rating from HC Wainwright by thelincolnianonline.com
Relay Therapeutics s stock had its buy rating reiterated by investment analysts at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They currently have a 19.00 price objective on the stock. HC Wainwrights target price would indicate a potential upside of 179.41 percent from the
Sage Therapeutic Valuation on October 14, 2024
It is possible to determine the worth of Sage Therapeutic on a given historical date. On October 14, 2024 Sage was worth 6.57 at the beginning of the trading date compared to the closed value of 6.81. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sage Therapeutic stock. Still, in general, we apply an absolute valuation method to find Sage Therapeutic's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sage Therapeutic where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sage Therapeutic's related companies.
| Open | High | Low | Close | Volume | |
| 6.33 | 6.78 | 6.20 | 6.59 | 659,917 | |
10/14/2024 | 6.57 | 6.82 | 6.50 | 6.81 | 761,670 |
| 6.87 | 7.04 | 6.82 | 6.86 | 357,395 |
| Backtest Sage Therapeutic | | | Sage Therapeutic History | | | Sage Therapeutic Valuation | Previous | Next |
Sage Therapeutic Trading Date Momentum on October 14, 2024
| On October 15 2024 Sage Therapeutic was traded for 6.86 at the closing time. The top price for the day was 7.04 and the lowest listed price was 6.82 . The trading volume for the day was 357.4 K. The trading history from October 15, 2024 was a factor to the next trading day price growth. The trading price change against the next closing price was 0.73% . The trading price change against the current closing price is 12.78% . |
Sage Therapeutic Fundamentals Correlations and Trends
By evaluating Sage Therapeutic's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sage Therapeutic's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sage financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sage Therapeutic Stock history
Sage Therapeutic investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sage Therapeutic will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sage Therapeutic stock prices may prove useful in developing a viable investing in Sage Therapeutic
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 59.8 M | 45.7 M | |
| Net Loss | -479.5 M | -455.5 M |
Sage Therapeutic Quarterly Net Working Capital |
|
Sage Therapeutic Stock Technical Analysis
Sage Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sage Therapeutic Period Price Range
Low | December 20, 2024
| High |
0.00 | 0.00 |
Sage Therapeutic cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sage Therapeutic December 20, 2024 Market Strength
Market strength indicators help investors to evaluate how Sage Therapeutic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sage Therapeutic shares will generate the highest return on investment. By undertsting and applying Sage Therapeutic stock market strength indicators, traders can identify Sage Therapeutic entry and exit signals to maximize returns
Sage Therapeutic Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sage Therapeutic's price direction in advance. Along with the technical and fundamental analysis of Sage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | (0.31) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |